L'Oreal says GLP-1 weight loss drugs are affecting beauty and skin care sales
L'Oreal's CEO says GLP-1 weight loss drugs are an important factor for the company as their use affects beauty and skin care sales.
AI-written summary · The Chestnut Post · · How we use AI
L'Oreal says the use of GLP-1 weight loss drugs is affecting sales of beauty and skin care products, according to BBC News.
The beauty giant's CEO described the drugs' use as a significant development for the company. The source summary did not specify whether the sales impact was positive or negative.
Originally reported by BBC News. Read the full story at BBC News
